Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented “Veto-Cell” technology addresses one of the most fundamental challenges in human immunology: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats. For more information, visit www.cell-source.com.